Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

Khalaf Kridin; Ralf J. Ludwig

doi:10.1016/j.jaad.2024.06.100

Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

Khalaf Kridin
, Ralf J. Ludwig

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e169-e170
Journal	Journal of the American Academy of Dermatology
Volume	91
Issue number	6
DOIs	https://doi.org/10.1016/j.jaad.2024.06.100
State	Published - Dec 2024
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CTCL
atopic dermatitis
dupilumab
mycosis fungoides

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2024.06.100

Cite this

@article{a8b2384f1ca248f68bcd6c32756cffdd,

title = "Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”",

keywords = "CTCL, atopic dermatitis, dupilumab, mycosis fungoides",

author = "Khalaf Kridin and Ludwig, \{Ralf J.\}",

year = "2024",

month = dec,

doi = "10.1016/j.jaad.2024.06.100",

language = "English",

volume = "91",

pages = "e169--e170",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier",

number = "6",

}

TY - JOUR

T1 - Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma

T2 - A retrospective cohort study”

AU - Kridin, Khalaf

AU - Ludwig, Ralf J.

PY - 2024/12

Y1 - 2024/12

KW - CTCL

KW - atopic dermatitis

KW - dupilumab

KW - mycosis fungoides

UR - https://www.scopus.com/pages/publications/85204562624

U2 - 10.1016/j.jaad.2024.06.100

DO - 10.1016/j.jaad.2024.06.100

M3 - Letter

C2 - 39116944

AN - SCOPUS:85204562624

SN - 0190-9622

VL - 91

SP - e169-e170

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -

Response to Hasan et al, “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this